SEP 15, 2020 9:21 AM PDT

Soy helps post-op treatment of bone cancer

New research published in the journal Acta Biomaterialia highlights the post-operative benefits of soy in treatment for bone cancer. While previous studies have suggested that soy is associated with reduced risk of cardiovascular disease, obesity, and cancer, as well as improved bone health, Washington State University scientists say that soy may also help patients during post-op chemotherapy.

Osteosarcoma, which affects mostly young people, is the second leading cause of cancer death in children. Standard treatment includes surgery to remove the tumor in addition to pre- and post-operative chemotherapy. The treatment is harsh and patients frequently have a lot inflammation from the surgery and bone reconstruction, in addition to the harmful side effects of chemotherapy. Unfortunately, osteosarcoma and metastatic bone cancer patients also often have a high rate of recurrence.

Led by WSU's School of Mechanical and Materials Engineering researchers Professor Susmita Bose and Naboneeta Sarkar, the study analyzed the effects of soy-based chemical compounds released slowly during chemotherapy. The goal of this treatment is to reduce inflammation. The team has taken a materials science angle in their research in order to develop biomedical devices that could be useful during cancer treatment.

"There is not much research in this area of natural medicinal compounds in biomedical devices," Bose said. "Using these natural medicines, one can make a difference to human health with very minimal or no side effects, although a critical issue remains composition control."

Soybeans have been spotlighted because of the beneficial properties of the compounds in them called isoflavones. These plant-derived estrogens are toxic to certain types of cancer cells while simultaneously not harmful to healthy cells. They have also been associated with bone health.

Photo: Pixabay

In conducting their research, the scientists 3D printed patient-specific, bone-like scaffolds composed of three soy compounds. They then used sample bone cancer cells and healthy cells to test a slow-release of the compounds into the cells. They found that while all three soy compounds reduced inflammation, two in particular significantly improved the growth of healthy bone cells and one resulted in a 90% reduction in bone cancer cell viability after only 11 days.

"These results advance our understanding in providing therapeutic approaches in using synthetic bone grafts as a drug delivery vehicle," Bose said. The team plans to continue their research in order to better understand the specific pathways of the genetic expression of soy.

Sources: Acta Biomaterialia, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JUL 15, 2020
Cancer
Traditional Medicine Reveals a New Anti-Cancer Drug
JUL 15, 2020
Traditional Medicine Reveals a New Anti-Cancer Drug
The art of traditional eastern medicine dates back thousands of years. It uses many unproven remedies, and many consider ...
JUL 13, 2020
Cancer
Breast cancer patients are 60% more likely to die of cancer after surviving a heart attack
JUL 13, 2020
Breast cancer patients are 60% more likely to die of cancer after surviving a heart attack
Unwelcome news from researchers at NYU Grossman School of Medicine suggests that breast cancer patients are 60% more lik ...
JUL 28, 2020
Clinical & Molecular DX
Cancer Diagnostics Go Skin Deep
JUL 28, 2020
Cancer Diagnostics Go Skin Deep
The average adult human has between 16 and 22 square feet of skin. This multifaceted organ serves a multitude of functio ...
AUG 03, 2020
Cell & Molecular Biology
Gut Microbes & Diet Change the Behavior of a Cancer-Driving Protein
AUG 03, 2020
Gut Microbes & Diet Change the Behavior of a Cancer-Driving Protein
Clinicians and researchers have long wondered why cancer is the small intestine is rare while it's so common in the colo ...
AUG 05, 2020
Cancer
A New Test to Analyze Cell-Free DNA in Cancer Diagnostics
AUG 05, 2020
A New Test to Analyze Cell-Free DNA in Cancer Diagnostics
Cell-free DNA (cfDNA) are small pieces of genomic DNA that have escaped into the bloodstream either through active relea ...
AUG 24, 2020
Cancer
Inhibiting Cancer Stem Cells to Stop Cancer Recurrence
AUG 24, 2020
Inhibiting Cancer Stem Cells to Stop Cancer Recurrence
Once upon a time, stem cells were the talk of the town. They really are amazing, with some capable of turning into any o ...
Loading Comments...